Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two

38Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hypothyroidism (HPT) HPT could be a risk factor for the development and progression of Alzheimer’s disease (AD). In addition, progressive neurodegeneration in AD may affect the metabolism of thyroid hormones (THs) in the brain causing local brain HPT. Hence, the present review aimed to clarify the potential association between HPT and AD. HPT promotes the progression of AD by inducing the production of amyloid beta (Aβ) and tau protein phosphorylation with the development of synaptic plasticity and memory dysfunction. Besides, the metabolism of THs is dysregulated in AD due to the accumulation of Aβ and tau protein phosphorylation leading to local brain HPT. Additionally, HPT can affect AD neuropathology through various mechanistic pathways including dysregulation of transthyretin, oxidative stress, ER stress, autophagy dysfunction mitochondrial dysfunction, and inhibition of brain-derived neurotrophic factor. Taken together there is a potential link between HPT and AD, as HPT adversely impacts AD neuropathology and the reverse is also true. Graphical Abstract: [Figure not available: see fulltext.].

Cite

CITATION STYLE

APA

AlAnazi, F. H., Al-kuraishy, H. M., Alexiou, A., Papadakis, M., Ashour, M. H. M., Alnaaim, S. A., … Batiha, G. E. S. (2023, October 1). Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two. Cellular and Molecular Neurobiology. Springer. https://doi.org/10.1007/s10571-023-01392-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free